CLINICAL_TRIALS
trial_result
· 2020-02-07
Clinical Trial Update: A Long-term Safety Study of QMF149 in Japanese Participants With Asthma [Phase 3]
Summary
A long-term safety study of QMF149 (likely a combination inhaler) in Japanese participants with asthma has completed Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2020-02-07